These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 17428708)

  • 61. Butterscotch masks the bitter taste of sumatriptan nasal spray.
    Blumenthal HJ
    Headache; 2001 Feb; 41(2):210. PubMed ID: 11251713
    [No Abstract]   [Full Text] [Related]  

  • 62. Frovatriptan for the acute treatment of migraine and prevention of predictable menstrual migraine.
    Elkind AH; MacGregor EA
    Expert Rev Neurother; 2008 May; 8(5):723-36. PubMed ID: 18457529
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Current therapies in childhood and adolescent migraine.
    Pakalnis A
    J Child Neurol; 2007 Nov; 22(11):1288-92. PubMed ID: 18006958
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sumatriptan nasal spray and cognitive function during migraine: results of an open-label study.
    Farmer K; Cady R; Bleiberg J; Reeves D; Putnam G; O'Quinn S; Batenhorst A
    Headache; 2001 Apr; 41(4):377-84. PubMed ID: 11318884
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Use of triptanes according to indications. Risk of infarct is not increased].
    MMW Fortschr Med; 2004 Feb; 146(7):60. PubMed ID: 15347059
    [No Abstract]   [Full Text] [Related]  

  • 66. New anti-migraine drugs: present and beyond the millennium.
    Limmroth V; Diener HC
    Int J Clin Pract; 1998; 52(8):566-70. PubMed ID: 10622056
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Triptans: actions and reactions.
    Nahas SJ; Silberstein SD
    Headache; 2008 Apr; 48(4):611-3. PubMed ID: 18377383
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The pharmacokinetics and clinical efficacy of AVP-825: a potential advancement for acute treatment of migraine.
    Cady R
    Expert Opin Pharmacother; 2015; 16(13):2039-51. PubMed ID: 26255952
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cluster headache: symptomatic treatment.
    Torelli P; Manzoni GC
    Neurol Sci; 2004 Oct; 25 Suppl 3():S119-22. PubMed ID: 15549518
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pediatric migraine.
    Lewis DW
    Neurol Clin; 2009 May; 27(2):481-501. PubMed ID: 19289227
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Zolmitriptan intranasal: a review of the pharmacokinetics and clinical efficacy.
    Goadsby PJ; Yates R
    Headache; 2006 Jan; 46(1):138-49. PubMed ID: 16412161
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Treatment of acute migraine with sumatriptan. Clinical experiences with advantages and disadvantages].
    Dahlöf C; Ekbom K; Persson L
    Lakartidningen; 1993 Sep; 90(38):3195-6, 3200. PubMed ID: 8231472
    [No Abstract]   [Full Text] [Related]  

  • 73. Pediatric migraine: recognition and treatment.
    Hershey AD; Winner PK
    J Am Osteopath Assoc; 2005 Apr; 105(4 Suppl 2):2S-8S. PubMed ID: 15928347
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.
    Oskoui M; Pringsheim T; Holler-Managan Y; Potrebic S; Billinghurst L; Gloss D; Hershey AD; Licking N; Sowell M; Victorio MC; Gersz EM; Leininger E; Zanitsch H; Yonker M; Mack K
    Neurology; 2019 Sep; 93(11):487-499. PubMed ID: 31413171
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
    Schreiber CP; Cady RK
    Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Pharmacotherapy: migraine and depression. Therapy with sumatripten and citalopram: perioperative anaesthesiological risk assessment].
    Ittner KP
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2006; 41(7-8):464-5. PubMed ID: 16874568
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Intranasal sumatriptan for the acute treatment of migraine in children.
    Wöber C; Wöber-Bingöl C
    Neurology; 2000 Mar; 54(5):1209-10. PubMed ID: 10720311
    [No Abstract]   [Full Text] [Related]  

  • 78. Pharmacological treatment of acute migraine in adolescents and children.
    Wöber-Bingöl Ç
    Paediatr Drugs; 2013 Jun; 15(3):235-46. PubMed ID: 23575981
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Probabilistic cost-effectiveness analysis of oral eletriptan in the treatment of acute migraine in Portugal].
    Félix JM; Inês MS; Acosta CM
    Acta Med Port; 2005; 18(1):77-87. PubMed ID: 16202337
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy and safety of tonabersat, a gap-junction modulator, in the acute treatment of migraine: a double-blind, parallel-group, randomized study.
    Dahlöf CG; Hauge AW; Olesen J
    Cephalalgia; 2009 Nov; 29 Suppl 2():7-16. PubMed ID: 19723121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.